Materials and methods for identifying human natural anti-Aß autoantibodies, as well as materials and methods for using such antibodies to treat Alzheimer's disease.
HUMAN MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN, AND THEIR USE AS THERAPEUTIC AGENTS